Skip to main content
. 2016 Nov 8;16:140. doi: 10.1186/s12890-016-0304-3

Table 3.

Lung function at baseline

Overall Treatment non-adherence based on Morisky-Green baseline score
High-Risk Low-Risk p-value
N = 114 27 (23.7) 87 (76.3)
Spirometry
 No n(%) 0 (0.0) ----- -----
 Yes, prior to the visit n(%) 75 (65.8) 13 (48.2) 62 (71.3) 0.027C
 Yes, during the visit n(%) 39 (34.2) 14 (51.8) 25 (28.7)
Spirometry results
 FVC (ml) - Mean (S.D.) 2485.4 (844.0) 2546.7 (788.7) 2466.4 (864) 0.668T
 FVC (%) - Mean (S.D.) 71.3 (19.4) 75.7 (21.7) 69.9 (18.6) 0.142U
 FEV1 (ml) - Mean (S.D.) 1239.7 (521.8) 1456.3 (544.9) 1172.5 (498.7) 0.013T
 FEV1 (%) - Mean (S.D.) 48.7 (17.4) 56.7 (17.8) 46.2 (16.6) 0.007U
 FEV1/FVC (%) - Mean (S.D.) 50.8 (13.2) 57.3 (10) 48.8 (13.5) 0.004U
 Missing n 0 0 0
GOLD stage
 Stage I: Mild (80 ≤ FEV1% ≤ 100) n(%) 6 (5.3) 2 (7.4) 4 (4.6) 0.074F
 Stage II: Moderate (50 ≤ FEV1% ≤ 79) n(%) 42 (36.8) 15 (55.6) 27 (31.0)
 Stage III: Severe (30 ≤ FEV1% ≤ 49) n(%) 50 (43.9) 7 (25.9) 43 (49.4)
 Stage IV: Very severe (FEV1% < 30) n(%) 16 (14.0) 3 (11.1) 13 (14.9)
 Missing n 0 0 0
O2 saturation (%)
 X (D.E.) 93.9 (3.0) 95.0 (2.7) 93.5 (3.0) 0.025U
 O2 saturation >90 % 98 (86.0) 25 (92.6) 73 (83.9) 0.351F
 Missing n 0 0 0
Minutes of walking per day
  < 30 n(%) 39 (34.2) 6 (22.2) 33 (37.9) 0.323C
 30–60 n(%) 36 (31.6) 10 (37.0) 26 (29.9)
  > 60 n(%) 39 (34.2) 11 (40.7) 28 (32.2)
 Missing n 0 0 0
Emphysema
 No n(%) 56 (49.1) 18 (66.7) 38 (43.7) 0.037C
 Yes n(%) 58 (50.9) 9 (33.3) 49 (56.3)
 Missing n 0 0 0
BODEx index
 Quartile 1: 0–2 points n(%) 28 (24.6) 12 (44.4) 16 (18.4) 0.011C
 Quartile 2: 3–4 points n(%) 44 (38.6) 11 (40.7) 33 (37.9)
 Quartile 3: 5–6 points n(%) 31 (27.2) 4 (14.8) 27 (31.0)
 Quartile 4: 7–10 points n(%) 11 (9.6) 0 (0.0) 11 (12.6)
 Missing n 0 0 0

S.D standard deviation

CChi-square test; FFisher’s exact test; T T-Test; UMann-Whitney U test